The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis.

PubWeight™: 5.38‹?› | Rank: Top 1%

🔗 View Article (PMC 140671)

Published in Mol Cell Biol on January 01, 2003

Authors

Michael W McBurney1, Xiaofeng Yang, Karen Jardine, Mary Hixon, Kim Boekelheide, John R Webb, Peter M Lansdorp, Madeleine Lemieux

Author Affiliations

1: Ottawa Regional Cancer Centre and Department of Medicine, University of Ottawa, Ontario K1H 1C4, Canada. michael.mcburney@orcc.on.ca

Articles citing this

(truncated to the top 100)

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature (2004) 10.32

Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A (2003) 9.14

Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol (2010) 8.55

Sirtuins in mammals: insights into their biological function. Biochem J (2007) 7.60

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell (2005) 6.79

Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol (2005) 5.54

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell (2008) 5.51

Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell (2008) 5.11

Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab (2009) 5.02

SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab (2008) 4.89

PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09

Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A (2004) 3.93

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab (2012) 3.69

SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One (2008) 3.66

Retracted SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell (2010) 3.58

Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev (2008) 3.46

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes (2009) 3.39

Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol (2006) 3.37

SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab (2008) 3.35

Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet (2010) 3.29

Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol (2004) 3.00

Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol (2003) 2.79

A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol (2005) 2.64

SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 2.49

Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell (2012) 2.46

The mammalian ovary from genesis to revelation. Endocr Rev (2009) 2.31

Phosphorylation regulates SIRT1 function. PLoS One (2008) 2.30

SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol (2005) 2.24

Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov (2012) 2.22

Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation (2010) 2.19

Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat Rev Endocrinol (2012) 2.12

Energetics, epigenetics, mitochondrial genetics. Mitochondrion (2009) 2.08

SIRT1: recent lessons from mouse models. Nat Rev Cancer (2010) 2.07

Sirt1-deficient mice exhibit an altered cartilage phenotype. Joint Bone Spine (2013) 2.06

The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest (2009) 2.02

Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev (2012) 1.99

Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab (2009) 1.89

SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem (2010) 1.86

Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev (2011) 1.85

SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest (2012) 1.82

Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol (2010) 1.78

miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) (2010) 1.76

Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity. J Neurosci (2010) 1.73

SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci (2010) 1.71

SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One (2010) 1.68

Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem (2010) 1.65

Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation. Endocrinology (2010) 1.65

Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc Natl Acad Sci U S A (2008) 1.62

The role of sirtuins in the control of metabolic homeostasis. Ann N Y Acad Sci (2009) 1.62

SIRT6 in DNA repair, metabolism and ageing. J Intern Med (2008) 1.61

The emerging and diverse roles of sirtuins in cancer: a clinical perspective. Onco Targets Ther (2013) 1.57

Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med (2009) 1.53

SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus. J Neurosci (2010) 1.51

Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci U S A (2010) 1.48

Sorting out functions of sirtuins in cancer. Oncogene (2013) 1.47

SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta (2010) 1.46

Calorie restriction and the exercise of chromatin. Genes Dev (2009) 1.44

Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol (2009) 1.44

CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS One (2009) 1.43

Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol Endocrinol (2007) 1.43

Axon pruning: an essential step underlying the developmental plasticity of neuronal connections. Philos Trans R Soc Lond B Biol Sci (2006) 1.43

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J (2010) 1.40

Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev (2010) 1.39

Sirtuins: guardians of mammalian healthspan. Trends Genet (2014) 1.36

SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood (2010) 1.36

An epigenetic perspective on the free radical theory of development. Free Radic Biol Med (2007) 1.35

Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD. Arch Biochem Biophys (2010) 1.34

BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. Arch Biochem Biophys (2005) 1.30

SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice. Breast Cancer Res (2007) 1.30

Dietary and metabolic control of stem cell function in physiology and cancer. Cell Stem Cell (2014) 1.29

Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell Cycle (2008) 1.28

Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation. Pharmacol Res (2009) 1.27

Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol (2012) 1.26

Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. Antioxid Redox Signal (2008) 1.26

Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell Metab (2013) 1.25

Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients. Neoplasia (2009) 1.25

Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription. Biochem J (2007) 1.19

SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling. Proc Natl Acad Sci U S A (2010) 1.19

Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol (2014) 1.18

The deacetylase enzyme SIRT1 is not associated with oxidative capacity in rat heart and skeletal muscle and its overexpression reduces mitochondrial biogenesis. J Physiol (2009) 1.17

Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition. Int J Biol Sci (2010) 1.16

SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol (2008) 1.16

SIRT1 negatively regulates the activities, functions, and protein levels of hMOF and TIP60. Mol Cell Biol (2012) 1.15

Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice. Ann Rheum Dis (2012) 1.14

Aging-like phenotype and defective lineage specification in SIRT1-deleted hematopoietic stem and progenitor cells. Stem Cell Reports (2014) 1.12

Sirtuin 1, stem cells, aging, and stem cell aging. Curr Opin Hematol (2008) 1.11

The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation. J Biol Chem (2011) 1.11

SIRT1 as a therapeutic target in inflammaging of the pulmonary disease. Prev Med (2011) 1.10

Sirt1 deficiency attenuates spermatogenesis and germ cell function. PLoS One (2008) 1.10

SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. J Biol Chem (2013) 1.09

Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. Circ Res (2014) 1.06

Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance. J Exp Med (2013) 1.06

Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence. Biochem Pharmacol (2012) 1.06

The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp Gerontol (2008) 1.04

Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy. J Mol Cell Cardiol (2011) 1.03

Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res (2010) 1.02

Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway. FASEB J (2013) 1.02

SIRT1-mediated acute cardioprotection. Am J Physiol Heart Circ Physiol (2011) 1.02

Induction of Sirt1 by mechanical stretch of skeletal muscle through the early response factor EGR1 triggers an antioxidative response. J Biol Chem (2010) 1.01

SIRT1 is dispensable for function of hematopoietic stem cells in adult mice. Blood (2012) 1.00

Articles cited by this

Translating the histone code. Science (2001) 56.77

DNA methylation patterns and epigenetic memory. Genes Dev (2002) 33.83

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature (2000) 20.54

Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A (1993) 20.33

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97

Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 15.05

Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature (2001) 14.44

The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev (1999) 14.43

Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science (2000) 12.98

Simplified mammalian DNA isolation procedure. Nucleic Acids Res (1991) 12.56

Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell (1993) 10.36

Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev (2000) 9.36

Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun (2000) 9.09

Role of insulin-like growth factors in embryonic and postnatal growth. Cell (1993) 8.22

The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A (2000) 7.92

Histone methylation in transcriptional control. Curr Opin Genet Dev (2002) 7.21

A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci U S A (2000) 6.49

Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J (2002) 6.37

Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell (2002) 6.25

Sir2 links chromatin silencing, metabolism, and aging. Genes Dev (2000) 5.95

The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev (1995) 5.55

Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci U S A (1997) 4.88

Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A (1994) 4.44

Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene (1987) 4.29

CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell (2002) 4.17

Chromatin profiling using targeted DNA adenine methyltransferase. Nat Genet (2001) 4.09

Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet (1996) 3.40

IGF-I is required for normal embryonic growth in mice. Genes Dev (1993) 3.17

The molecular biology of the SIR proteins. Gene (2001) 3.05

Common themes in mechanisms of gene silencing. Mol Cell (2001) 2.88

The human histone deacetylase family. Exp Cell Res (2001) 2.86

The interaction of Alba, a conserved archaeal chromatin protein, with Sir2 and its regulation by acetylation. Science (2002) 2.69

Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product. Proc Natl Acad Sci U S A (2000) 2.61

Why is p53 acetylated? Cell (2001) 2.42

Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol Cell Biol (1991) 2.36

The conserved core of a human SIR2 homologue functions in yeast silencing. Mol Biol Cell (1999) 2.07

Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol (2001) 2.05

Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev (1994) 1.91

Drosophila Sir2 is required for heterochromatic silencing and by euchromatic Hairy/E(Spl) bHLH repressors in segmentation and sex determination. Cell (2002) 1.81

The role of the tumor suppressor p53 in spermatogenesis. Cell Death Differ (1998) 1.52

Sir2p exists in two nucleosome-binding complexes with distinct deacetylase activities. EMBO J (2001) 1.39

dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster. Exp Cell Res (2001) 1.24

hADA3 is required for p53 activity. EMBO J (2001) 1.22

Murine PGK-1 promoter drives widespread but not uniform expression in transgenic mice. Dev Dyn (1994) 1.21

p53-mediated germ cell quality control in spermatogenesis. Dev Biol (1998) 1.04

Testicular wild-type p53 expression in transgenic mice induces spermiogenesis alterations ranging from differentiation defects to apoptosis. Oncogene (1999) 1.00

DNA methylation pattern of a tandemly repeated LacZ transgene indicates that most copies are silent. Dev Dyn (1999) 0.99

The family of mouse phosphoglycerate kinase genes and pseudogenes. Somat Cell Mol Genet (1988) 0.91

Importance of the IGF system in early folliculogenesis. Mol Cell Endocrinol (2000) 0.89

Gene silencing in the development of cancer. Exp Cell Res (1999) 0.89

Recent discoveries in physiology of insulin-like growth factor-1 and its interaction with gonadotropins in folliculogenesis. Endocrine (2001) 0.87

Guidelines for mating rodents. Curr Protoc Toxicol (2002) 0.84

Articles by these authors

Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med (2004) 12.20

Mammalian SIRT1 represses forkhead transcription factors. Cell (2004) 8.89

Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med (2007) 8.23

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest (2008) 6.15

Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol (2005) 5.54

Telomeres and aging. Physiol Rev (2008) 4.79

TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12

Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc (2006) 4.00

Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 3.86

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86

SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One (2008) 3.66

Disruption of dog-1 in Caenorhabditis elegans triggers deletions upstream of guanine-rich DNA. Nat Genet (2002) 3.50

OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest (2004) 3.38

Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res (2009) 3.29

Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res (2011) 2.94

Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell (2004) 2.91

Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet (2003) 2.76

Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood (2003) 2.73

Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell (2010) 2.64

TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell (2004) 2.62

NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol (2008) 2.44

Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 2.44

BET bromodomains mediate transcriptional pause release in heart failure. Cell (2013) 2.17

The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A (2005) 2.01

Single-atom catalysis of CO oxidation using Pt1/FeOx. Nat Chem (2011) 1.98

Genome-wide mRNA profiling reveals heterochronic allelic variation and a new imprinted gene in hybrid maize endosperm. Plant J (2003) 1.95

Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res (2006) 1.95

CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J Exp Med (2004) 1.92

DNA template strand sequencing of single-cells maps genomic rearrangements at high resolution. Nat Methods (2012) 1.85

The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells. Mol Cancer Res (2003) 1.85

Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev (2010) 1.81

Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat Res (2011) 1.79

NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reprod Toxicol (2002) 1.78

Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice. Blood (2011) 1.77

Fetal mouse phthalate exposure shows that Gonocyte multinucleation is not associated with decreased testicular testosterone. Toxicol Sci (2007) 1.75

Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica (2011) 1.71

sirt1-null mice develop an autoimmune-like condition. Exp Cell Res (2008) 1.67

2,5-hexanedione and carbendazim coexposure synergistically disrupts rat spermatogenesis despite opposing molecular effects on microtubules. Toxicol Sci (2004) 1.63

Synchrony of telomere length among hematopoietic cells. Exp Hematol (2010) 1.63

Mutations in the SBDS gene in acquired aplastic anemia. Blood (2007) 1.62

Telomerase levels control the lifespan of human T lymphocytes. Blood (2003) 1.59

People of the British Isles: preliminary analysis of genotypes and surnames in a UK-control population. Eur J Hum Genet (2011) 1.58

A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One (2009) 1.57

Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood (2006) 1.57

Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes. PLoS Genet (2012) 1.57

Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling. Sci Transl Med (2012) 1.54

RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability. Mol Cell Biol (2006) 1.54

Detection of G-quadruplex DNA in mammalian cells. Nucleic Acids Res (2013) 1.53

Identification of sister chromatids by DNA template strand sequences. Nature (2009) 1.53

Genome-wide transcript analysis of maize hybrids: allelic additive gene expression and yield heterosis. Theor Appl Genet (2006) 1.52

Phthalate esters in human milk: concentration variations over a 6-month postpartum time. Environ Sci Technol (2006) 1.52

Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol (2005) 1.52

Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res (2007) 1.50

Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia-telangiectasia. Hum Mol Genet (2003) 1.48

A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C. J Mol Cell Cardiol (2004) 1.48

Absence of p53 and FasL has sexually dimorphic effects on both development and reproduction. Exp Biol Med (Maywood) (2002) 1.46

Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry (2002) 1.43

A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors. Vaccine (2011) 1.41

Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Blood (2005) 1.37

Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med (2003) 1.37

Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH. Cytometry A (2003) 1.36

Estimating human hematopoietic stem cell kinetics using granulocyte telomere lengths. Exp Hematol (2004) 1.33

SirT1 fails to affect p53-mediated biological functions. Aging Cell (2006) 1.33

Functional characterization of telomerase RNA variants found in patients with hematologic disorders. Blood (2004) 1.33

Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood (2007) 1.31

Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation (2009) 1.30

NTP-CERHR Expert Panel Update on the Reproductive and Developmental Toxicity of di(2-ethylhexyl) phthalate. Reprod Toxicol (2006) 1.30

Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis. PLoS Genet (2011) 1.29

Telomere length in subpopulations of human hematopoietic cells. Stem Cells (2003) 1.28

RTEL1 contributes to DNA replication and repair and telomere maintenance. Mol Biol Cell (2012) 1.28

MR∕PET quantification tools: registration, segmentation, classification, and MR-based attenuation correction. Med Phys (2012) 1.28

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant. Vaccine (2002) 1.28

Longitudinal data on telomere length in leukocytes from newborn baboons support a marked drop in stem cell turnover around 1 year of age. Aging Cell (2006) 1.28

Hematopoietic stem-cell behavior in nonhuman primates. Blood (2007) 1.27

RTEL1: an essential helicase for telomere maintenance and the regulation of homologous recombination. Nucleic Acids Res (2010) 1.27

A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG. J Nucl Med (2008) 1.25

Telomere length in human natural killer cell subsets. Ann N Y Acad Sci (2007) 1.25

Dose-dependent effects of sertoli cell toxicants 2,5-hexanedione, carbendazim, and mono-(2-ethylhexyl) phthalate in adult rat testis. Toxicol Pathol (2007) 1.25

Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. Exp Cell Res (2004) 1.21

Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res (2002) 1.20

Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts. Aging Cell (2007) 1.20

Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924. Cancer Cell (2012) 1.19

Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res (2012) 1.18

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res (2013) 1.18

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes. J Transl Med (2012) 1.16

Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease. J Pathol (2012) 1.15

Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci U S A (2010) 1.15

NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-butyl phthalate. Reprod Toxicol (2002) 1.15

Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS One (2008) 1.14

Stem cells: hype and reality. Hematology Am Soc Hematol Educ Program (2002) 1.14

Evidence for repeat-induced gene silencing in cultured Mammalian cells: inactivation of tandem repeats of transfected genes. Exp Cell Res (2002) 1.13

Integrative DNA methylation and gene expression analyses identify DNA packaging and epigenetic regulatory genes associated with low motility sperm. PLoS One (2011) 1.13

Hyperhomocysteinemia inhibits post-injury reendothelialization in mice. Cardiovasc Res (2005) 1.12

Fas is involved in the p53-dependent apoptotic response to ionizing radiation in mouse testis. Biol Reprod (2002) 1.10

Telomeres, telomerase, and hematopoietic stem cell biology. Arch Med Res (2004) 1.10

The mouse polyubiquitin gene Ubb is essential for meiotic progression. Mol Cell Biol (2007) 1.10